T3	Subject 114 122	patients
T4	Subject 619 634;653 682	Twenty patients aged 35 to 65 (50 Â± 12) years
T5	Anatomical_entity 1729 1733	BALF
T6	Anatomical_entity 1940 1946	matrix
T7	Disorder 1197 1200	IPF
T11	GGPs 1716 1721	MMP-7
T13	Subject 1528 1536	patients
T15	Subject 1270 1278	patients
T18	GGPs 2081 2086	MMP-7
T22	Anatomical_entity 304 308	BALF
T24	Disorder 1435 1446	sarcoidosis
T25	Anatomical_entity 274 302	bronchoalveolar lavage fluid
T29	GGPs 1871 1876	MMP-1
T30	Disorder 950 961	sarcoidosis
T31	Subject 848 856	patients
T33	Disorder 128 157	idiopathic pulmonary fibrosis
T35	GGPs 11 37	matrix metalloproteinase-1
T36	Anatomical_entity 809 821	BALF samples
T38	GGPs 1366 1371	MMP-7
T39	Disorder 532 535	IPF
T41	Disorder 1967 1980	lung fibrosis
T42	Anatomical_entity 1504 1509	serum
T43	GGPs 1215 1220	MMP-1
T46	Subject 1089 1097	patients
T49	GGPs 1988 1993	MMP-7
T53	Anatomical_entity 1175 1179	BALF
T54	GGPs 880 885	MMP-1
T57	Disorder 1103 1114	sarcoidosis
T59	GGPs 1519 1524	MMP-7
T62	Subject 313 321	patients
T63	GGPs 247 252	MMP-7
T68	Subject 491 501;523 528	Forty-four cases
T69	Anatomical_entity 2018 2024	matrix
T70	Subject 1183 1191	patients
T72	Anatomical_entity 72 77	serum
T73	Anatomical_entity 839 844	serum
T74	Anatomical_entity 82 110	bronchoalveolar lavage fluid
T75	Subject 936 944	patients
T76	Disorder 1542 1545	IPF
T79	Disorder 327 356	idiopathic pulmonary fibrosis
T80	GGPs 782 787	MMP-7
T83	Disorder 1284 1295	sarcoidosis
T85	Disorder 640 651	sarcoidosis
T86	GGPs 772 777	MMP-1
T87	GGPs 42 68	matrix metalloproteinase-7
T88	Disorder 862 865	IPF
T89	Anatomical_entity 795 800;814 821	serum samples
T91	Disorder 477 480	IPF
T92	Disorder 2141 2144	IPF
T93	Subject 1421 1429	patients
T99	GGPs 1032 1037	MMP-7
T100	Disorder 358 361	IPF
N5	Reference T3 UMLS:C0030705	Patients
N7	Reference T4 UMLS:C0030705	Patients
N9	Reference T5 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N19	Reference T7 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N30	Reference T11 UMLS:C0166059	Matrix Metalloproteinase 7
N34	Reference T13 UMLS:C0030705	Patients
N45	Reference T15 UMLS:C0030705	Patients
N54	Reference T18 UMLS:C0166059	Matrix Metalloproteinase 7
N79	Reference T22 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N85	Reference T24 UMLS:C0036202	Sarcoidosis
N87	Reference T25 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N106	Reference T30 UMLS:C0036202	Sarcoidosis
N109	Reference T31 UMLS:C0030705	Patients
N116	Reference T33 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N129	Reference T36 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N138	Reference T38 UMLS:C0166059	Matrix Metalloproteinase 7
N140	Reference T39 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N145	Reference T41 UMLS:C0034069	Pulmonary Fibrosis
N151	Reference T42 UMLS:C0229671	Serum
N162	Reference T46 UMLS:C0030705	Patients
N171	Reference T49 UMLS:C0166059	Matrix Metalloproteinase 7
N192	Reference T53 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N204	Reference T57 UMLS:C0036202	Sarcoidosis
N219	Reference T59 UMLS:C0166059	Matrix Metalloproteinase 7
N225	Reference T62 UMLS:C0030705	Patients
N230	Reference T63 UMLS:C0166059	Matrix Metalloproteinase 7
N266	Reference T70 UMLS:C0030705	Patients
N274	Reference T72 UMLS:C0229671	Serum
N279	Reference T73 UMLS:C0229671	Serum
N280	Reference T74 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N282	Reference T75 UMLS:C0030705	Patients
N285	Reference T76 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N293	Reference T79 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N299	Reference T80 UMLS:C0166059	Matrix Metalloproteinase 7
N311	Reference T83 UMLS:C0036202	Sarcoidosis
N323	Reference T85 UMLS:C0036202	Sarcoidosis
N330	Reference T87 UMLS:C0166059	Matrix Metalloproteinase 7
N332	Reference T88 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N343	Reference T91 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N346	Reference T92 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N348	Reference T93 UMLS:C0030705	Patients
N372	Reference T100 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
T101	Disorder 162 173	sarcoidosis
N1	Reference T101 UMLS:C0036202	Sarcoidosis
T102	Disorder 367 389	sarcoidosis (Stage II)
N4	Reference T102 UMLS:C0340198	Stage 2 pulmonary sarcoidosis
N6	Reference T35 UMLS:C0127082	Interstitial Collagenase
N8	Reference T86 UMLS:C0127082	Interstitial Collagenase
N11	Reference T43 UMLS:C0127082	Interstitial Collagenase
N12	Reference T29 UMLS:C0127082	Interstitial Collagenase
T27	GGPs 212 242	matrix metalloprotease (MMP)-1
N15	Reference T27 UMLS:C0127082	Interstitial Collagenase
N10	Reference T99 UMLS:C0166059	Matrix Metalloproteinase 7
T28	Method_cue 703 738	Enzyme-linked immunoabsorbent assay
N18	Reference T54 UMLS:C0127082	Interstitial Collagenase
N13	Reference T6 UMLS:C0015350	Extracellular Matrix
N14	Reference T69 UMLS:C0015350	Extracellular Matrix
T8	Subject 114 122	patients
N17	Reference T8 UMLS:C0030705	Patients
T32	Subject 313 321	patients
N20	Reference T32 UMLS:C0030705	Patients
R1	Subject_Disorder Arg1:T8 Arg2:T33	
R2	Subject_Disorder Arg1:T3 Arg2:T101	
R3	Subject_Disorder Arg1:T32 Arg2:T79	
R4	Subject_Disorder Arg1:T62 Arg2:T102	
R5	Subject_Disorder Arg1:T4 Arg2:T85	
R6	Subject_Disorder Arg1:T31 Arg2:T88	
R7	Subject_Disorder Arg1:T75 Arg2:T30	
R8	Subject_Disorder Arg1:T46 Arg2:T57	
R9	Subject_Disorder Arg1:T70 Arg2:T7	
R10	Subject_Disorder Arg1:T15 Arg2:T83	
R11	Subject_Disorder Arg1:T93 Arg2:T24	
R12	Subject_Disorder Arg1:T13 Arg2:T76	
T14	Positive_regulation 1884 1893	increased
E3	Positive_regulation:T14 Theme:T29 Cue:T44
N22	Reference E3 UMLS:C1879547	Activation action
T21	Positive_regulation 2001 2010	increased
E4	Positive_regulation:T21 Theme:T49 Cue:T47
N24	Reference E4 UMLS:C1879547	Activation action
T52	Biological_process 461 473	pathogenesis
E5	Biological_process:T52 Theme:T91
N26	Reference E5 UMLS:C0699748	Pathogenesis
R15	Subject_Disorder Arg1:T68 Arg2:T39	
T55	Measurement 1581 1618	diffusing capacity of carbon monoxide
N28	Reference T55 UMLS:C1516251	Carbon Monoxide Diffusing Capability Test
T58	Measurement 1769 1806	diffusing capacity of carbon monoxide
N29	Reference T58 UMLS:C1516251	Carbon Monoxide Diffusing Capability Test
N16	Reference T28 UMLS:C0014441	Enzyme-Linked Immunosorbent Assay
T9	Biological_process 1947 1957	remodeling
E2	Biological_process:T9 Theme:T6
N23	Reference E2 UMLS:C1820201	tissue remodeling
T17	Biological_process 2025 2035	remodeling
E6	Biological_process:T17 Theme:T69
N31	Reference E6 UMLS:C1820201	tissue remodeling
T20	Measurement 1651 1676	percentage of neutrophils
N35	Reference T20 UMLS:C1171400	Neutrophil percentage measurement
T34	Biological_process 1901 1913	inflammatory
E1	Biological_process:T34 
N32	Reference E1 UMLS:C0021368	Inflammation
T23	Biological_process 2061 2073	inflammatory
E7	Biological_process:T23 
N36	Reference E7 UMLS:C0021368	Inflammation
T37	Correlation 1752 1763	correlation
E8	Correlation:T37 Theme:T11 Theme2:T58 Cue:T26
N37	Reference E8 UMLS:C0332281	Associated with
T40	Correlation 1561 1571	correlated
E9	Correlation:T40 Theme:T59 Theme2:T55 Theme3:T20
N38	Reference E9 UMLS:C0332281	Associated with
N27	Reference T68 UMLS:C0030705	Patients
N21	Reference T89 UMLS:C1550100	Specimen Type - Serum
R16	part_of Arg1:T73 Arg2:T31	
R17	part_of Arg1:T53 Arg2:T70	
R18	part_of Arg1:T42 Arg2:T13	
T44	Speculation_cue 1877 1880	may
A1	Speculated E3
T47	Speculation_cue 1994 1997	may
T61	Anatomical_entity 260 265	serum
N41	Reference T61 UMLS:C0229671	Serum
A2	Speculated E4
R19	part_of Arg1:T72 Arg2:T3	
R20	part_of Arg1:T74 Arg2:T3	
R21	part_of Arg1:T72 Arg2:T8	
R22	part_of Arg1:T74 Arg2:T8	
R23	part_of Arg1:T61 Arg2:T62	
R24	part_of Arg1:T25 Arg2:T62	
R25	part_of Arg1:T61 Arg2:T32	
R26	part_of Arg1:T22 Arg2:T32	
T26	Speculation_cue 1734 1740	showed
A3	Speculated E8
